HomeOpen Access NewsDiseases & Conditions

Diseases & Conditions

Raising awareness: Why stroke care matters

The Young Stroke Physicians and Researchers (YSPR) Committee, composed of young members of the European Stroke Organisation, is dedicated to promoting the involvement of young stroke physicians and researchers in the ESO and the broader field of stroke care. On behalf of the YSPR, Dr Sarah Gorey highlights some key challenges in stroke-related care, as well as recent innovations in treatment.

Foot test can detect heart rhythm disorder in diabetic patients

A simple annual foot test can help detect atrial fibrillation in patients with diabetes, according to research presented at EHRA 2021.

Huntington’s disease (HD) research

Dr. James E Goldman and Dr. Osama Al-Dalahmah from the Department of Pathology and Cell Biology at Columbia University, provide an in-depth perspective on Huntington’s disease (HD) research.

The rudiments of stroke prevention

Juliet Bouverie, Chief Executive of the Stroke Association, on inspiring people to reduce their risk of stroke.

Driving the epilepsy field ahead with new research benchmarks

The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), drives the epilepsy field ahead with new research benchmarks, Vicky Whittemore, PhD, Program Director reveals.

Africa: Strengthening public health surveillance systems

Several seasoned academic experts describe the move towards strengthening public health surveillance systems in Africa.

Curative approach to severe autoimmune diseases

Andrew Mackie, VP Business Development tells us how Imcyse, a Belgian immunotherapy expert, seeks a curative approach to severe autoimmune diseases.

A simple prescription for healing chronic disease

Dr Shireen Kassam MBBS, FRCPath, PhD, dipIBLM, Founder and Director of Plant-Based Health Professionals UK, explains a simple prescription for health as a remedy to chronic disease.

From insulin to immunotherapy: A century of discovery

Dr Faye Riley, Senior Research Communications Officer at Diabetes UK, highlights how immunotherapy is raising hopes for the next big breakthrough in type 1 diabetes.

Identifying dementia & mild cognitive impairment

Dr Timothy Kwok, Professor at The Chinese University of Hong Kong, shares the development of the Electronic Cognitive Screen (EC-Screen) for population screening of dementia in older people.

Innovation in chronic disease prevention 

Dr Eugene Durenard, CEO of Hyperbolic Holdings GmbH discusses promising emerging technologies in the field of early detection and prevention of major chronic diseases.

Plague: The first pandemic disease

Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill, writes in detail about plague, the first pandemic disease including comment on bacteria.

Arthritis impacts six million Canadians and counting

Dr Siân Bevan, Chief Science Officer of the Arthritis Society describes how arthritis impacts six million Canadians and counting.

Huntington’s disease: Present concern & therapeutic view

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, describes the present concern and future therapeutic perspective on Huntington’s disease.

How has COVID-19 affected people with lung conditions?

The impact of COVID-19 has proven that we cannot let people with lung conditions continue to be forgotten, says Dr Alison Cook, Chair of the Taskforce for Lung Health.

The role of the mind in dis-ease

We hear from emotional trauma expert and renowned healer, Antonia Harman about the role of the mind in dis-ease.

Is the UK heading for a “perfect storm” of diabetes referrals?

Here, a leading clinical negligence specialist warns the UK may be heading for a “perfect storm” of diabetes complications, due to delayed COVID-19 referrals.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders